Skip to main content

Advertisement

SpringerLink
Log in

Prognostic factors in T3b renal cell carcinoma

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Objectives

We reviewed our patients with pathologic T3b renal cell carcinoma (RCC) to determine which factors influenced survival in this high risk patient group.

Methods

From April 1988 to August 2006, 722 patients underwent nephrectomy for RCC at Vanderbilt University. 128 patients (17%) had T3b disease by 2002 AJCC TNM staging criteria. 31 (24%) of these patients had known metastases at the time of nephrectomy. Patient demographics, clinical, and pathological characteristics were collected.

Results

There were 95 men (74%) and 33 women (26%) whose median age was 64 years (range 35–87). Median follow-up was 25.2 months (0–124). Median follow-up among those still alive at last follow up was 45.8 months (2.4–114). For overall survival (OS), disease specific survival (DSS), and recurrence free survival (RFS), non-clear cell histology, grade, presence of sarcomatoid features, LN positive disease, presence of necrosis, positive margins, and metastasis present at the time of nephrectomy were all associated with worse outcomes. Race, gender, ASA class, age, and inferior vena cava (IVC) involvement were not associated with outcome. On multivariate analysis, metastasis at the time of nephrectomy, margin involvement, and the presence of necrosis were independently associated with decreased OS and DSS. The presence of necrosis and lymph node involvement were independent predictors of worse RFS.

Conclusions

Our data suggests that in patients with T3b RCC, the presence or absence of macroscopic necrosis should be included as part of the pathology report to help guide prognosis in this high risk patient group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Yongping H, Xu J, Murray T, Thun M (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96. doi:10.3322/CA.2007.0010

    Article  PubMed  Google Scholar 

  2. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H (2004) The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94(1):33–41. doi:10.1111/j.1464-410X.2004.04897.x

    Article  PubMed  Google Scholar 

  3. Tanaka M, Fujimoto K, Okajima E, Tanaka N, Yoshida K, Hirao Y (2008) Prognostic factors of renal cell carcinoma with extension into inferior vena cava. Int J Urol 15(5):394–398. doi:10.1111/j.1442-2042.2008.02017.x

    Article  PubMed  Google Scholar 

  4. Trombetta C, Liguori G, Bucci S, Benvenuto S, Garaffa G, Belgrano E (2007) Evaluation of tumor thrombi in the inferior vena cava with intraoperative ultrasound. World J Urol 25(4):381–384. doi:10.1007/s00345-007-0191-6

    Article  PubMed  Google Scholar 

  5. Zisman A, Wieder JA, Pantuck AJ et al (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169(3):909–916. doi:10.1097/01.ju.0000045706.35470.1e

    Article  PubMed  Google Scholar 

  6. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16(6):2261–2266

    PubMed  CAS  Google Scholar 

  7. Klatte T, Pantuck AJ, Riggs SB, et al. (2007) Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 178(4 pt 1):1189–1195. doi:10.1016/j.juro.2007.05.134 (discussion 95)

    Google Scholar 

  8. Leibovich BC, Cheville JC, Lohse CM et al (2005) Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol 173(3):716–719. doi:10.1097/01.ju.0000151830.27750.d2

    Article  PubMed  Google Scholar 

  9. Ficarra V, Artibani W (2006) Staging system of renal cell carcinoma: current issues. Eur Urol 49(2):223–225. doi:10.1016/j.eururo.2005.11.018

    Article  PubMed  Google Scholar 

  10. Libertino JA, Zinman L, Watkins E Jr (1987) Long-term results of resection of renal cell cancer with extension into inferior vena cava. J Urol 137(1):21–24

    PubMed  CAS  Google Scholar 

  11. Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145(1):20–23; discussion 3–4

    Google Scholar 

  12. Sosa RE, Muecke EC, Vaughan ED Jr, McCarron JP Jr (1984) Renal cell carcinoma extending into the inferior vena cava: the prognostic significance of the level of vena caval involvement. J Urol 132(6):1097–1100

    PubMed  CAS  Google Scholar 

  13. Parekh DJ, Cookson MS, Chapman W et al (2005) Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol 173(6):1897–1902. doi:10.1097/01.ju.0000158459.42658.95

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The project described was supported by Award Number K08 CA113452 (P.E.C) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest statement

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN, 37232-2765, USA

    Benjamin J. Coons, Andrew A. Stec, Kelly L. Stratton, Sam S. Chang, Michael S. Cookson, S. Duke Herrell, Joseph A. Smith Jr & Peter E. Clark

Authors
  1. Benjamin J. Coons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew A. Stec
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kelly L. Stratton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sam S. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael S. Cookson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Duke Herrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joseph A. Smith Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter E. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter E. Clark.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coons, B.J., Stec, A.A., Stratton, K.L. et al. Prognostic factors in T3b renal cell carcinoma. World J Urol 27, 75–79 (2009). https://doi.org/10.1007/s00345-008-0358-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-008-0358-9

Keywords

Search

Navigation